shutterstock_2026137224_flowersandtraveling
Flowersandtraveling / Shutterstock.com
8 December 2022Big PharmaStaff Writer

Pfizer and partner hit back in COVID-19 vaccine dispute

Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Americas
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Americas
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.